KFF COVID-19 Vaccine Monitor: April 2021

Findings
  1. After the field work was completed, the researchers analyzed whether attitudes towards the safety of the Johnson & Johnson vaccine changed during the field period, notably after the pause was lifted. No significant differences on this measure were noted.

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.